Axcella Health Inc. (AXLA:NASDAQ) soared at $10.57, representing a gain of 53%. On Thu, Sep 28, 2023, AXLA:NASDAQ touched a New 2-Week Intraday Low of $6.65. The stock got featured on our News Catalysts scanner on Tue, Sep 26, 2023 at 02:45 PM in the 'BIOTECH' category. From Thu, Sep 14, 2023, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Wed, Sep 13, 2023 at $41.25 with a volume of 3M+.
About Axcella Health Inc. (AXLA:NASDAQ)
Axcella Health Inc a biotechnology company involved in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. Its AXA candidates are generated from its proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs. The company's pipeline comprises of five programs focused on the metabolic functions of the liver, muscle and blood.
Top 10 Gainers:
- Bionomics Limited (BNOX:NASDAQ), 243.84%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Chico's FAS, Inc. (CHS:NYSE), 63.12%
- Axcella Health Inc. (AXLA:NASDAQ), 52.97%
- Baudax Bio, Inc. (BXRX:NASDAQ), 50.67%
- Aytu BioScience, Inc. (AYTU:NASDAQ), 39.06%
- Sarcos Technology and Robotics Corporation (STRC:NASDAQ), 37.31%
- Femasys Inc. (FEMY:NASDAQ), 36.94%
- Vaccinex, Inc. (VCNX:NASDAQ), 34.82%
- Infinity Pharmaceuticals, Inc. (INFI:NASDAQ), 34.4%